2-[[(3R,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-N-[(2S,4R,5R)-2-[(3R,4R)-4-ethoxy-6-hydroxy-2-(hydroxymethyl)-5-methyloxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide

C44H75NO11 — CID 58091678

IUPAC2-[[(3R,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-N-[(2S,4R,5R)-2-[(3R,4R)-4-ethoxy-6-hydroxy-2-(hydroxymethyl)-5-methyloxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
SMILESCCO[C@@H]1C(C)C(O)OC(CO)[C@@H]1O[C@@H]1OC(CO)[C@H](O)[C@H](O)C1NC(=O)CO[C@@H]1CC[C@@]2(C)C(=CCC3C2CC[C@@]2(C)C3CC[C@@H]2[C@H](C)CCCC(C)C)C1
InChIInChI=1S/C44H75NO11/c1-8-52-39-26(5)41(51)54-34(22-47)40(39)56-42-36(38(50)37(49)33(21-46)55-42)45-35(48)23-53-28-16-18-43(6)27(20-28)12-13-29-31-15-14-30(25(4)11-9-10-24(2)3)44(31,7)19-17-32(29)43/h12,24-26,28-34,36-42,46-47,49-51H,8-11,13-23H2,1-7H3,(H,45,48)/t25-,26?,28-,29?,30-,31?,32?,33?,34?,36?,37+,38-,39-,40+,41?,42+,43+,44-/m1/s1
InChIKeyBCSHGJNYAVGKDS-JUVLUXPJSA-N
MW794.08 g/mol
LogP4.47
Rot. Bonds15

About 2-[[(3R,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-N-[(2S,4R,5R)-2-[(3R,4R)-4-ethoxy-6-hydroxy-2-(hydroxymethyl)-5-methyloxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide

2-[[(3R,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-N-[(2S,4R,5R)-2-[(3R,4R)-4-ethoxy-6-hydroxy-2-(hydroxymethyl)-5-methyloxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide (PubChem CID 58091678) has the molecular formula C44H75NO11 and a molecular weight of 794.08 g/mol. Its IUPAC name is 2-[[(3R,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-N-[(2S,4R,5R)-2-[(3R,4R)-4-ethoxy-6-hydroxy-2-(hydroxymethyl)-5-methyloxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide.

Molecular Properties

Compound Name2-[[(3R,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-N-[(2S,4R,5R)-2-[(3R,4R)-4-ethoxy-6-hydroxy-2-(hydroxymethyl)-5-methyloxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
PubChem CID58091678
Molecular FormulaC44H75NO11
Molecular Weight794.08 g/mol
Exact Mass793.53
IUPAC Name2-[[(3R,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-N-[(2S,4R,5R)-2-[(3R,4R)-4-ethoxy-6-hydroxy-2-(hydroxymethyl)-5-methyloxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
SMILESCCO[C@@H]1C(C)C(O)OC(CO)[C@@H]1O[C@@H]1OC(CO)[C@H](O)[C@H](O)C1NC(=O)CO[C@@H]1CC[C@@]2(C)C(=CCC3C2CC[C@@]2(C)C3CC[C@@H]2[C@H](C)CCCC(C)C)C1
InChIInChI=1S/C44H75NO11/c1-8-52-39-26(5)41(51)54-34(22-47)40(39)56-42-36(38(50)37(49)33(21-46)55-42)45-35(48)23-53-28-16-18-43(6)27(20-28)12-13-29-31-15-14-30(25(4)11-9-10-24(2)3)44(31,7)19-17-32(29)43/h12,24-26,28-34,36-42,46-47,49-51H,8-11,13-23H2,1-7H3,(H,45,48)/t25-,26?,28-,29?,30-,31?,32?,33?,34?,36?,37+,38-,39-,40+,41?,42+,43+,44-/m1/s1
InChIKeyBCSHGJNYAVGKDS-JUVLUXPJSA-N
XLogP4.47
TPSA176.40 Ų
H-Bond Donors6
H-Bond Acceptors11
Rotatable Bonds15
Heavy Atoms56
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500794.08
LogP ≤ 54.47
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze 2-[[(3R,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-N-[(2S,4R,5R)-2-[(3R,4R)-4-ethoxy-6-hydroxy-2-(hydroxymethyl)-5-methyloxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[[(3R,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-N-[(2S,4R,5R)-2-[(3R,4R)-4-ethoxy-6-hydroxy-2-(hydroxymethyl)-5-methyloxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide?
The IUPAC name of 2-[[(3R,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-N-[(2S,4R,5R)-2-[(3R,4R)-4-ethoxy-6-hydroxy-2-(hydroxymethyl)-5-methyloxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide (CID 58091678) is 2-[[(3R,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-N-[(2S,4R,5R)-2-[(3R,4R)-4-ethoxy-6-hydroxy-2-(hydroxymethyl)-5-methyloxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide.
What is the SMILES notation for 2-[[(3R,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-N-[(2S,4R,5R)-2-[(3R,4R)-4-ethoxy-6-hydroxy-2-(hydroxymethyl)-5-methyloxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide?
The canonical SMILES for 2-[[(3R,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-N-[(2S,4R,5R)-2-[(3R,4R)-4-ethoxy-6-hydroxy-2-(hydroxymethyl)-5-methyloxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide is CCO[C@@H]1C(C)C(O)OC(CO)[C@@H]1O[C@@H]1OC(CO)[C@H](O)[C@H](O)C1NC(=O)CO[C@@H]1CC[C@@]2(C)C(=CCC3C2CC[C@@]2(C)C3CC[C@@H]2[C@H](C)CCCC(C)C)C1.
What is the InChIKey of 2-[[(3R,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-N-[(2S,4R,5R)-2-[(3R,4R)-4-ethoxy-6-hydroxy-2-(hydroxymethyl)-5-methyloxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide?
The InChIKey is BCSHGJNYAVGKDS-JUVLUXPJSA-N. The full InChI is InChI=1S/C44H75NO11/c1-8-52-39-26(5)41(51)54-34(22-47)40(39)56-42-36(38(50)37(49)33(21-46)55-42)45-35(48)23-53-28-16-18-43(6)27(20-28)12-13-29-31-15-14-30(25(4)11-9-10-24(2)3)44(31,7)19-17-32(29)43/h12,24-26,28-34,36-42,46-47,49-51H,8-11,13-23H2,1-7H3,(H,45,48)/t25-,26?,28-,29?,30-,31?,32?,33?,34?,36?,37+,38-,39-,40+,41?,42+,43+,44-/m1/s1.
What are the key properties of 2-[[(3R,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-N-[(2S,4R,5R)-2-[(3R,4R)-4-ethoxy-6-hydroxy-2-(hydroxymethyl)-5-methyloxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide?
2-[[(3R,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-N-[(2S,4R,5R)-2-[(3R,4R)-4-ethoxy-6-hydroxy-2-(hydroxymethyl)-5-methyloxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide has a molecular weight of 794.08 g/mol, XLogP of 4.47, 15 rotatable bonds, 6 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[[(3R,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-N-[(2S,4R,5R)-2-[(3R,4R)-4-ethoxy-6-hydroxy-2-(hydroxymethyl)-5-methyloxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide is sourced from PubChem (CID 58091678), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).